Related Experiment Video
Updated: Aug 11, 2026

07:10
Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Murine models for acquired immune deficiency syndrome
1Department of Family and Community Medicine, Arizona Health Sciences Center, University of Arizona, Tucson 85724.
Life Sciences
|January 1, 1989
Summary
Murine retroviruses, like LP-BM5, offer a promising model for studying Human Acquired Immune Deficiency Syndrome (AIDS). These models mimic key immunological changes seen in AIDS, aiding research into vaccines and treatments.
Area of Science:
- Immunology
- Virology
- Comparative Medicine
Background:
- Mice are valuable models for studying Human Acquired Immune Deficiency Syndrome (AIDS).
- Existing models involve incorporating parts of the Human Immunodeficiency Virus (HIV) genome into mice.
- Murine retroviruses offer a more comprehensive approach to modeling AIDS-related immunological changes.
Purpose of the Study:
- To review the effects of murine retroviruses on immune systems.
- To highlight the potential of the LP-BM5 murine leukemia virus model for AIDS research.
- To discuss the advantages of using murine models for studying AIDS.
Main Methods:
- Review of scientific literature on murine retroviruses and their effects on the immune system.
- Focus on LP-BM5 murine leukemia virus infection in mice.
- Analysis of immunological changes induced by murine retroviruses.
Main Results:
- LP-BM5 murine leukemia virus infects T cells, B cells, and macrophages.
- LP-BM5 infection leads to suppressed cell functions and polyclonal lymphocyte activation.
- Murine retroviruses induce functional immune changes similar to those observed in Human Immunodeficiency Syndrome (AIDS).
Conclusions:
- The LP-BM5 murine leukemia virus model is a promising tool for AIDS research.
- Advantages include immunological similarity to human AIDS, cost-effectiveness, and availability of mouse strains.
- This model facilitates studies on vaccine development, drug testing, and cofactor involvement in disease progression.

